-+ 0.00%
-+ 0.00%
-+ 0.00%

10x Genomics Raises FY2026 Sales Guidance from $600.000M-$625.000M to $610.000M-$630.000M vs $613.851M Est

Benzinga·08/06/2026 20:07:43
Listen to the news
10x Genomics (NASDAQ:TXG) raises FY2026 sales outlook from $600.000 million-$625.000 million to $610.000 million-$630.000 million vs $613.851 million estimate.